The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

To the Editor: Hypopituitarism, also known as Simmonds’ disease, occurs most commonly from pituitary tumors and a head injury, though a fracture of the base of the skull is considered a rare cause. Traumatic brain injury leads to significant disability and endocrine dysfunction in approximately 59% of patients.1 Its signs and symptoms overlap with the neurological and psychiatric sequelae so often misdiagnosed.

Alterations in circulating levels of hormones occur hours or days after trauma, may represent adaptive responses to injury, and are influenced by the type of injury and therapy in the acute phase of injury2

Endocrine manifestations of hypopituitarism reveal deficiencies of specific hormones leading to hypoadrenocorticotropinemia, hypothyroidism, and hypogonadism. Deficiency in corticotropin levels is characterized by decreased levels of adrenal androgens and decreased production of cortisol. Acute loss of adrenal function is a medical emergency and may lead to hypotension and death if not treated. Signs and symptoms of corticotropin deficiency include myalgias, arthralgias, fatigue, headache, weight loss, anorexia, nausea, vomiting, abdominal pain, altered mentation or altered consciousness, dry wrinkled skin, loss of axillary and pubic hair, anemia, and impaired gluconeogenesis.3,4 Studies have implied that pituitary dysfunction can be diagnosed years after the initial insult.5

Case Report

A 38-year-old man with a history of a road traffic accident 11 years ago was referred from the Medicine Department. He had been experiencing gradually increasing fatigue, decreased interest in pleasurable activities, irritability, and decreased libido for the last 10 years. He would frequently complain of nausea and headache. His symptoms gradually progressed, and he also experienced cold intolerance, constipation, malaise, arthralgia, and somnolence. Physical examination findings revealed a thin-built man, conscious and oriented, with normal vital functions. General physical, systemic, and neurological examination findings were normal. His mental status examination revealed reduced psychomotor activity, depressed affect, ideas of worthlessness, and impaired concentration. Results of laboratory testing (with reference ranges) included luteinizing hormone levels of 1.7 mIU/mL (2–12 mIU/mL), follicle-stimulating hormone levels of 6.2 mIU/mL (2–17 mIU/mL), testosterone levels of 0.01 nmol/L (6.7–28.9 nmol/L), basal cortisol levels of 0.23 µg/dL (0.39–0.69 µg/dL), prolactin levels of 0.28 ng/mL (2.5–16.7 ng/mL), free T3 levels of 1.3 pmol/L (6.5–21.0 pmol/L), free T4 levels of 1.1 pmol/L (10–23 pmol/L), and thyroid-stimulating hormone levels of 0.06 mIU/L (0.5–4.5 mIU/L).

Results on MRI brain scans revealed bilateral frontotemporal posttraumatic encephalomalacia with gliosis and ex vacuo changes, likely posttraumatic sequelae. The patient was prescribed long-term replacement therapy of hydrocortisone 20 mg twice daily and thyroxine 100 μg daily. He showed remarkable improvement.

Discussion

In this case report, we emphasize the importance of an endocrine workup in patients with traumatic brain injury presenting with depressive symptoms, which can lead to early diagnosis and reduction in morbidity and mortality risks due to a misdiagnosis of hypopituitarism as a depressive disorder.

Dept. of Psychiatry, University College of Medical Sciences, New Delhi, Delhi, India (MSB, PG, AR, JK, SS); and the Dept. of Psychiatry, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, Delhi, India (AR).
Correspondence: Manjeet Singh Bhatia, M.D.; e-mail:
References

1 Lieberman SA, Oberoi AL, Gilkison CR, et al.: Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab 2001; 86:2752–2756MedlineGoogle Scholar

2 Bondanelli M, Ambrosio MR, Zatelli MC, et al.: Hypopituitarism after traumatic brain injury. Eur J Endocrinol 2005; 152:679–691Crossref, MedlineGoogle Scholar

3 Lamberts SW, de Herder WW, van der Lely AJ: Pituitary insufficiency. Lancet 1998; 352:127–134Crossref, MedlineGoogle Scholar

4 Benvenga S, Campenní A, Ruggeri RM, et al.: Hypopituitarism secondary to brain trauma. J Clin Endocrinol Metab 2000; 85:1353–1361Crossref, MedlineGoogle Scholar

5 Eledrisi MS, Urban RJ, Lieberman SA: Brain injury and neuroendocrine function. Endocrinologist 2001; 11:275–281CrossrefGoogle Scholar